{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:17:31Z","timestamp":1767626251154},"reference-count":27,"publisher":"Academy of Managed Care Pharmacy","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMCP"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.18553\/jmcp.2020.20052","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T16:15:11Z","timestamp":1591892111000},"page":"971-980","source":"Crossref","is-referenced-by-count":8,"title":["Estimation of Total Costs in Pediatric and Young Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Receiving Tisagenlecleucel from a U.S. Hospital\u2019s Perspective"],"prefix":"10.18553","volume":"26","author":[{"given":"Hongbo","family":"Yang","sequence":"first","affiliation":[{"name":"Analysis Group, Boston, Massachusetts."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanni","family":"Hao","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation, East Hanover, New Jersey."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia Z.","family":"Qi","sequence":"additional","affiliation":[{"name":"Analysis Group, Boston, Massachusetts."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinglei","family":"Chai","sequence":"additional","affiliation":[{"name":"Analysis Group, Boston, Massachusetts."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric Q.","family":"Wu","sequence":"additional","affiliation":[{"name":"Analysis Group, Boston, Massachusetts."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7818","reference":[{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21219"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.53"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0117-0"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-374710"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.8554"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.251"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.3301"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866"},{"key":"B11","unstructured":"Kymriah (tisagenlecleucel) suspension for intravenous infusion. Novartis Pharmaceuticals Corporation. May 2018. Available at: https:\/\/www.fda.gov\/files\/vaccines%2C%20blood%20%26%20biologics\/published\/Package-Insert-KYMRIAH.pdf. Accessed May 27, 2020."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.229781"},{"key":"B14","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/blood-2019-129279","volume":"134","author":"Grupp S","year":"2019","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.583"},{"issue":"6","key":"B20","first-page":"236","volume":"114","author":"Hsu BS","year":"2015","journal-title":"WMJ"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.0977"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.79.0642"},{"issue":"7","key":"B27","first-page":"366","volume":"10","author":"Broder MS","year":"2017","journal-title":"Am Health Drug Benefits"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2217\/ijh-2016-0001"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2017.1384373"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.29"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.03.002"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-453175"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.12.493"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1080\/20016689.2019.1601484"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.09.2841"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3310\/hta21070"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1413-8"}],"container-title":["Journal of Managed Care & Specialty Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T10:50:16Z","timestamp":1595847016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmcp.org\/doi\/10.18553\/jmcp.2020.20052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.18553\/jmcp.2020.20052"],"URL":"https:\/\/doi.org\/10.18553\/jmcp.2020.20052","relation":{},"ISSN":["2376-0540","2376-1032"],"issn-type":[{"value":"2376-0540","type":"print"},{"value":"2376-1032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}